Skip to main content
Equibles

Kevin Caliendo

Analyst

UBS

Equibles does not estimate personal net worth.

About Kevin Caliendo

Kevin Caliendo is recorded as Analyst at UBS. Kevin Caliendo has spoken on 45 earnings calls and 2 other investor events across 13 companies, most recently for Envista Holdings Corp on September 17, 2026. Those appearances were for Accendra Health Inc (ACH), Quest Diagnostics Inc (DGX), Cencora, Inc. (COR), Henry Schein Inc (HSIC), Envista Holdings Corp (NVST) and 8 other companies. The companies whose calls Kevin Caliendo spoke on are classified in the Healthcare sector.

Kevin Caliendo on recent calls

“I'm just wondering how that's impacting the business as we're hearing these anecdotal stories.”
Analyst — UBS, 2026 Envista Investor Day ·
“I want to talk a little bit about the organic growth assumption that you have. How much of that is volume growth? How much of that is sort of rev rec or pricing?”
Analyst — UBS, Labcorp Holdings Inc. 2026 Investor Day ·
“We do expect year-over-year growth in each of the subsequent quarters on an ex-IEPA tariff refund basis.”
Analyst — UBS, Cardinal Health Inc Q4 FY2026 Earnings Call ·
“I hope it all works out well for you and the company and the like, but congrats.”
Analyst — UBS, Accendra Health Inc/Va/ Q2 FY2026 Earnings Call ·
“I wanted to talk a little bit, Mario, I just want to ask you, you went through a whole process with your contracting and how you thought about reserving for it.”
Analyst — UBS, Evolent Health, Inc. Q2 FY2026 Earnings Call ·

Affiliation history

  • UBS

    Analyst

    Source not stated

    Current

Company network

Recent activity

Show 35 earlier activities